Clinical, endocrine and metabolic studies in the kindred of familial partial lipodystrophy - A syndrome of insulin resistance

Journal of Association of Physicians of India

Volumn 50, Issue 6, 2002, Pages 773-776

  Vaidya, R A ^a   Vaidya, A D B ^a   Talwalkar, S C ^a   Mehtalia, S D ^b   Shringi, M S ^a   Pandey, S N ^a   Shah, S J ^a   Godse, C ^a   Joshi, J V ^a   Sheth, J ^b   Kamdar, V V ^c  

^a Bharatiya Vidya Bhavan's Swami Prakashananda Ayurveda Research Centre   (India)

^b Bhavan's SPARC   (India)

^c Bhavan's SPARC VKAN ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ENDOCRINE GLAND; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; METABOLISM; MIDDLE AGED; SYNDROME;

ADOLESCENT; ADULT; AGED; CHILD; ENDOCRINE GLANDS; FEMALE; HUMANS; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; MIDDLE AGED; SYNDROME;

EID: 0036599478     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kobberling J, Willms B, Kattermann R, Creutzfeldt W. Lipodystrophy of the extremities : A dominantly inherited syndrome associated with lipoartophic diabetes. Humangenetik 1975;29:111-20.
2. Dunnigan ME, Cochrane MA, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med 1974;49:33-48.
3. Kahn CR, Flier JS, Bar RS, et al. The syndrome of insulin resistance and acanthosis nigricans : insulin receptor disorders in men. N Engl J Med 1976;294:739-45.
4. Garg A. Lipodystrophies. Am J Med 2000;108:143-52.
5. Seip M, Trygstad O. Generalised lipodystrophy, congenital and acquired (lipoatrophy). Acta Pediatr Suppl 1996;413:2-28.
6. Garg A, Fleckenstein JL, Peshock RM, Grundy SM. Peculiar distribution of adipose tissue in patients with congenital generalised lipodystrophy. J Clin Endocrinol Metab 1992;75:358-61.
7. Vaidya RA, Shringi MS, Mehtalia SD, Talwalkar SC, Vaidya AB. Pictorial CME. Familial insulin resistance syndrome -Kahn type A with face sparing lipodystrophy. J Assoc Physicians India 1998;46:705.
8. Hegele RA. Insulin resistance in human partial lipodystrophy. Curr Antheroscler Rep 2000;2:397-404.
9. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002;25:S5-S20.
10. Ganda OP. Lipoatrophy, lipodystrophy and insulin resistance (editorial). Ann Intern Med 2000;133:304-6.
11. Foster DW. The lipodystrophies and other rare disorders of adipose tissue. In : Fauci AS, Braunwald E, Isselbacher KJ, et al, editors. Harrison's Principles of Internal Medicine. 14th ed. New York : Mc Graw-Hill. 1998;2209-12.
12. Garg A, Wilson R, Barnes R, et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 1999;84:3390-4.
13. Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A. Localisation of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nature Genet 1998;18:292-5.
14. Cao H, Hegele RA. Nuclear lamin AJC R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000;9:109-12.
15. Hegele RA. Molecular basis of partial lipodystrophy and prospects for therapy. Trends Mol Med 2001;7:121-6.
16. Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 2000;85:1776-82.
17. Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 1999;84:170-4.
18. Vaidya RA, Shringi MS, Vaidya AB, et al. Serum leptin concentrations in hyperinsulinemia in the sets of obese, lipodystrophic and/or non-obese patients. J Assoc Physicians India 1999;47:584-8.
19. Hegele RA, Cao H, Huff MW, Anderson CM. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endocrinol Metab 2000;85:3089-93.
20. Vaidya RA, Shringi MS, Vaidya AB, Gogate JG. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen-progestogen in HAIR-AN Syndrome. J Assoc Physicians India 1997;45:883-4.